A permanent cardiac pacing for symptomatic bradycardia has been achieved with systems that consist of a surgically implanted subcutaneous electrical generator connected to one or more transvenous leads that deliver the pacing therapy to the heart.
Despite the clinical introduction of these pacemakers, pacemaker-related adverse events occur in 1 in 10 patients. These events are typically related to the transvenous lead, surgical pocket, or pulse generator.
Percutaneous solution for heart blocks and severe bradycardia is present with selective indications only.
What are the benefits of Micra?
Unlike most pacemakers that are placed in the patient's chest with leads running to the heart, Micra is implanted directly into the patient's heart.
Redefined Patient Experience
- No chest scar
- No bump
- No visible or physical reminder of a pacemaker under the skin
- Fewer post implant activity restrictions
Eliminated Pocket-Related Complications
- Erosion-Eliminated Lead-Related
Complications with Traditional Systems
- Pocket-related complications: 8% at 5 years
- Lead-related complications: 11% at 5 years
Dr. Viveka Kumar says, "It is a relief especially for elderly patients, people having lung infection, on hemodialysis with shunts, oncology patients undergoing radiotherapy, patients with other comorbidities, and patients with indication of single chamber pacemaker implantation".